DavidFStefanikMD

PubMed

• Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate.
  Stefanik, D.,Sarin, J.,Lam, T.,Levin, L.,Leboy, P. S.,Akintoye, S. O.> ;Oral Dis. 2008 Oct 22
• 11 citations
  A dose verification method using a monitor unit matrix for dynamic IMRT on Varian linear accelerators
  Xuangen Chen, Ning Yue, Weimin Chen, Cheng B. Saw, Dwight E. Heron, David Stefanik, Richard Antemann, M. Saiful Huq> ;Physics in Medicine and Biology. 2005 Dec 7
• 83 citations
  Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft.
  David F. Stefanik, Wendy Fellows, Laila R. Rizkalla, Waheeb M. Rizkalla, Paulette P. Stefanik, Albert B. DeLeo, William C. Welch> ;Journal of Neuro-Oncology. 2001 Nov 1
• 13 citations
  Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes.
  Paul V. Woolley, Susanne M. Gollin, Waheeb Riskalla, Sydney D. Finkelstein, David F. Stefanik, Laila Riskalla, William P. Swaney, Larry Weisenthal, Robert J. McKenna> ;Molecular Diagnosis. 2000 Sep 1
• 4 citations
  Acidic and basic fibroblast growth factors are present in glioblastoma multiforme and normal brain.
  David F. Stefanik, Laila R. Rizkalla, Anuradha Soi, Sidney A. Goldblatt, Waheeb M. Rizkalla> ;Annals of the New York Academy of Sciences. 1991 Dec 1
• 111 citations
  Acidic and basic fibroblast growth factors are present in glioblastoma multiforme.
  David F. Stefanik, Laila R. Rizkalla, Anuradha Soi, Sidney A. Goldblatt, Waheeb M. Rizkalla> ;Cancer Research. 1991 Oct 15
• Assessment of "best practice" treatment patterns for a "radiation oncology community outreach group" engaged in cancer disparities outcomes.
  de Andrade, R. S., Proctor, J. W., Rakfal, S. M., Werts, E. D., Schenken, L. L., Saw, C. B., Dougherty, M., Stefanik, D.> ;J Am Coll Radiol. 2008 Apr
• Join now to see all